← Back to Search

Behavioral Intervention

Computerized Intervention for Teen Substance Abuse (CARS Trial)

N/A
Recruiting
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, one-week follow-up, and three-month follow-up

Summary

This trialstudies a computerized treatment for teens aged 13-17 in South Carolina with alcohol/cannabis use. Follow-ups will be taken 1 & 3 months after treatment.

Who is the study for?
This trial is for young people aged 13-17 who are looking for help with alcohol or cannabis use and have used both in the past three months. They must be willing to seek treatment and have a caregiver who can consent to their participation. Pregnant or breastfeeding individuals cannot join.
What is being tested?
The study tests a computerized task called modified Approach-Avoidance Task (mAAT) designed to change automatic tendencies towards substance use. Participants will either receive mAAT that aims to modify this bias or one that does not, assessing its effectiveness over time.
What are the potential side effects?
Since the intervention is a behavioral computerized task, there are no direct physical side effects like those associated with medication. However, participants may experience psychological discomfort if confronting substance-related cues.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and three-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and three-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change Cannabis Approach Bias (D-Score)
Change in Cannabis Approach Bias (D-Score)
Change in alcohol use as assessed by Timeline Followback
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Group A: Treatment GroupExperimental Treatment1 Intervention
Group II: Group B: Control GroupPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
979 Previous Clinical Trials
7,400,942 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,763 Total Patients Enrolled

Media Library

modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias. (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05486234 — N/A
Substance Use Disorder Clinical Trial 2023: modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias. Highlights & Side Effects. Trial Name: NCT05486234 — N/A
Substance Use Disorder Research Study Groups: Group A: Treatment Group, Group B: Control Group
modified Approach-Avoidance Task (mAAT) that does not aim to modify automatic approach bias. (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05486234 — N/A
~12 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top